{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:46:07Z","timestamp":1770957967922,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Eboka Majolene B"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jpba.2016.06.025","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T20:18:07Z","timestamp":1467058687000},"page":"504-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A highly sensitive LC\u2013MS\/MS method for determination of ketoconazole in human plasma: Application to a clinical study of the exposure to ketoconazole in patients after topical administration"],"prefix":"10.1016","volume":"128","author":[{"given":"Keli","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2016.06.025_bib0005","first-page":"185","article-title":"Diagnosis and treatment of seborrheic dermatitis","volume":"91","author":"Clark","year":"2015","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jpba.2016.06.025_bib0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1087-0024.2005.10119.x","article-title":"Three etiologic facets of dandruff and seborrheic dermatitis: malassezia fungi, sebaceous lipids, and individual sensitivity","volume":"10","author":"DeAngelis","year":"2005","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"10.1016\/j.jpba.2016.06.025_bib0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.01.001","article-title":"Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies","volume":"31","author":"Dessinioti","year":"2013","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.jpba.2016.06.025_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/17469872.3.1.15","article-title":"Ketoconazole 2% foam for treatment of seborrheicdermatitis","volume":"3","author":"Rolz-Cruz","year":"2008","journal-title":"Expert Rev. Dermatol."},{"key":"10.1016\/j.jpba.2016.06.025_bib0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14740338.2015.983071","article-title":"Drug safety assessment of oral formulations of ketoconazole","volume":"14","author":"Gupta","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jpba.2016.06.025_bib0030","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/1203475415574970","article-title":"A.K. gupta, D.C., lyons, the rise and fall of oral ketoconazole","volume":"19","year":"2015","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.jpba.2016.06.025_bib0035","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s13233-012-0107-1","article-title":"Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent","volume":"20","author":"Ramasamy","year":"2012","journal-title":"Macromol. Res."},{"key":"10.1016\/j.jpba.2016.06.025_bib0040","article-title":"Seborrheic dermatitis of the scalp in populations practicing less frequent hair washing: ketoconazole 2% foam versus ketoconazole 2% shampoo. Three-year data","volume":"70","author":"Chappell","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jpba.2016.06.025_bib0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/09546630802286993","article-title":"An open randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis","volume":"20","author":"Koc","year":"2009","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jpba.2016.06.025_bib0050","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/14656566.8.9.1365","article-title":"A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanism","volume":"8","author":"Faergemann","year":"2007","journal-title":"Expert Opin. Pharmacol."},{"key":"10.1016\/j.jpba.2016.06.025_bib0055","article-title":"Ketoconazole 2% foam in the treatment of mild to severe seborrheic dermatitis","volume":"58","author":"Elewski","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jpba.2016.06.025_bib0060","article-title":"The vehicle found in ketoconazole foam 2% is preferred by patients with mild to severe seborrheic dermatitis over other vehicles regardless of gender, age, or ethnicity","volume":"58","author":"Cash","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jpba.2016.06.025_bib0065","first-page":"5365","article-title":"Evaluation of bioequivalence of two formulations containing 200mg of ketoconazole","volume":"19","author":"Solomon","year":"2007","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.jpba.2016.06.025_bib0070","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-0033-1363966","article-title":"Quantitative determination of ketoconazole by UPLC-MS\/MS in human plasma and its application to pharmacokinetic study","volume":"64","author":"Hu","year":"2014","journal-title":"Drug Res."},{"key":"10.1016\/j.jpba.2016.06.025_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13318-014-0235-4","article-title":"CYP3A4-based drug\u2013drug interaction: CYP3A4 substrates' pharmacokinetic properties and ketoconazole dose regimen effect","volume":"41","author":"Boulenc","year":"2016","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jpba.2016.06.025_bib0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jchromb.2014.11.030","article-title":"Simultaneous determination of tazarotene and its active metabolite tazarotenic acid in minipig plasma by LC-MS\/MS and its application in pharmacokinetic study after topical administration of tazarotene gel","volume":"978","author":"Tong","year":"2015","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2016.06.025_bib0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jpainsymman.2006.11.005","article-title":"Topical agents for the management of musculoskeletal pain","volume":"33","author":"Stanos","year":"2007","journal-title":"J. Pain Symp. Manage."},{"key":"10.1016\/j.jpba.2016.06.025_bib0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.2042-7158.1996.tb05933.x","article-title":"Permeation characteristics of 8-methoxypsoralen through human skin; Relevance to clinical treatment","volume":"48","author":"Anigbogu","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jpba.2016.06.025_bib0095","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1039\/C5AY00468C","article-title":"Self-assembly pipette tip-based cigarette filters for micro-solid phase extraction of ketoconazole cis-enantiomers in urine samples followed by high-performance liquid chromatography\/diode array detection","volume":"7","author":"Andrade","year":"2015","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jpba.2016.06.025_bib0100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpba.2010.04.018","article-title":"High performance liquid chromatographic assay for the simultaneous determination of midazolam and ketoconazole in plasma","volume":"53","author":"Hamdy","year":"2010","journal-title":"J. Pharm. Biomed."},{"key":"10.1016\/j.jpba.2016.06.025_bib0105","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jpba.2009.06.030","article-title":"Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection","volume":"50","author":"Gordien","year":"2009","journal-title":"J. Pharm. Biomed."},{"key":"10.1016\/j.jpba.2016.06.025_bib0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1570-0232(02)00209-X","article-title":"Determination of ketoconazole in human plasma by high-performance liquid chromatography \u2013 tandem mass spectrometry","volume":"774","author":"Chen","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2016.06.025_bib0115","series-title":"U.S., Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER)","year":"2007"},{"key":"10.1016\/j.jpba.2016.06.025_bib0120","series-title":"U.S., Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Guidance for Industry, Bioanalytical Method Validation","year":"2013"},{"key":"10.1016\/j.jpba.2016.06.025_bib0125","first-page":"605","article-title":"Ketoconazole associated hepatotoxicity: a systematic review and meta-analysis","volume":"26","author":"Yan","year":"2013","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.jpba.2016.06.025_bib0130","series-title":"U.S., Department of Health and Human Services (DHHS),;1; Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), NIZORAL\u00ae (ketoconazole) Tablets","year":"2013"},{"key":"10.1016\/j.jpba.2016.06.025_bib0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jac\/8.4.299","article-title":"Pharmacokinetics of ketoconazole in normal subjects","volume":"8","author":"Daneshmend","year":"1981","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516303429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516303429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T22:54:34Z","timestamp":1536620074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708516303429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":27,"alternative-id":["S0731708516303429"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2016.06.025","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A highly sensitive LC\u2013MS\/MS method for determination of ketoconazole in human plasma: Application to a clinical study of the exposure to ketoconazole in patients after topical administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2016.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}